Alfonso Duenas Gonzalez, Medical Oncologist and Senior Researcher at the National Cancer Institute of Mexico, shared a post on X:
“TRULY AMAZING!!!!
Arrieta O, Cardona AF, Wagner-Gutiérrez N, de Lima VCC, Saldanha EF, Corrales L, Freitas HC, Santana LG, Martín C, Enrico D, Motta R, Zuluaga J, Rojas L, Ruiz-Patiño A, Cruz G, Valencia Á, Viola L, Mejía S, Martínez S, Carvajal C, Sánchez N, Gutierrez L, de Las Salas B, Raez L, Rolfo C, on behalf CLICaP.
Clinicogenomic and Treatment Outcomes in RET Fusion-Positive NSCLC: A Multicenter Study in Latin American Hispanic Patients.
Methods: This retrospective multicenter study evaluated clinical, genomic, and treatment-related outcomes in patients with advanced RET fusion-positive NSCLC across five Latin American countries.”
Title: Clinicogenomic and Treatment Outcomes in RET Fusion-Positive NSCLC: A Multicenter Study in Latin American Hispanic Patients
Authors: Oscar Arrieta, Andrés F Cardona, Nicolle Wagner-Gutiérrez, Vladmir Cláudio Cordeiro de Lima, Erick Figueiredo Saldanha, Luis Corrales, Helano Carioca Freitas, Leonardo Gil Santana, Claudio Martín, Diego Enrico, Rodrigo Motta, Jairo Zuluaga, Leonardo Rojas, Alejandro Ruiz-Patiño, Graciela Cruz, Ángel Valencia, Lucia Viola, Sergio Mejía, Stella Martínez, Carlos Carvajal, Natalia Sánchez, Liliana Gutierrez, Briegel de Las Salas, Luis Raez, Christian Rolfo
Other articles about NSCLC on OncoDaily.